Graziela Cerchiaro

843 total citations
11 papers, 624 citations indexed

About

Graziela Cerchiaro is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Graziela Cerchiaro has authored 11 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 4 papers in Immunology and 3 papers in Neurology. Recurrent topics in Graziela Cerchiaro's work include Multiple Sclerosis Research Studies (7 papers), Systemic Lupus Erythematosus Research (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Graziela Cerchiaro is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Systemic Lupus Erythematosus Research (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Graziela Cerchiaro collaborates with scholars based in Canada, United States and Brazil. Graziela Cerchiaro's co-authors include Paulina Sannomiya, Cristóforo Scavone, Tatiana Carolina Alba‐Loureiro, Carolina Demarchi Munhoz, Joilson O. Martins, Rui Curi, Luanne M. Metz, Yuti Chernajovsky, Jun Hirabayashi and Ken‐ichi Kasai and has published in prestigious journals such as New England Journal of Medicine, Neurology and Annals of Neurology.

In The Last Decade

Graziela Cerchiaro

11 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graziela Cerchiaro Canada 7 205 178 94 92 77 11 624
Pijus Barman United States 10 356 1.7× 152 0.9× 22 0.2× 112 1.2× 85 1.1× 11 761
Hajime Ishinaga Japan 18 192 0.9× 298 1.7× 91 1.0× 80 0.9× 112 1.5× 75 1.0k
Rafael S. Czepielewski United States 15 352 1.7× 275 1.5× 40 0.4× 216 2.3× 88 1.1× 27 1.0k
Ying Sheng China 19 78 0.4× 493 2.8× 39 0.4× 82 0.9× 39 0.5× 76 1.0k
Başak Kayhan Türkiye 14 190 0.9× 161 0.9× 147 1.6× 129 1.4× 64 0.8× 28 659
Hassan Nikoueinejad Iran 12 189 0.9× 111 0.6× 42 0.4× 95 1.0× 33 0.4× 48 538
Xiaoli Lou China 18 129 0.6× 233 1.3× 34 0.4× 142 1.5× 29 0.4× 44 650
Paula Restrepo-Jiménez Colombia 9 157 0.8× 144 0.8× 57 0.6× 141 1.5× 11 0.1× 13 675
Jingjing Wu China 16 139 0.7× 302 1.7× 63 0.7× 123 1.3× 22 0.3× 52 763

Countries citing papers authored by Graziela Cerchiaro

Since Specialization
Citations

This map shows the geographic impact of Graziela Cerchiaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graziela Cerchiaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graziela Cerchiaro more than expected).

Fields of papers citing papers by Graziela Cerchiaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graziela Cerchiaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graziela Cerchiaro. The network helps show where Graziela Cerchiaro may publish in the future.

Co-authorship network of co-authors of Graziela Cerchiaro

This figure shows the co-authorship network connecting the top 25 collaborators of Graziela Cerchiaro. A scholar is included among the top collaborators of Graziela Cerchiaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graziela Cerchiaro. Graziela Cerchiaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhang, Yunyan, Weiqiao Liu, G. Bruce Pike, et al.. (2024). Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatment. Multiple Sclerosis and Related Disorders. 85. 105525–105525. 2 indexed citations
2.
Cámara-Lemarroy, Carlos R., Luanne M. Metz, Jens Kühle, et al.. (2022). Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels. Multiple Sclerosis Journal. 28(13). 2081–2089. 6 indexed citations
3.
Cámara-Lemarroy, Carlos R., Cláudia Silva, Luanne M. Metz, et al.. (2021). Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosis. Multiple Sclerosis and Related Disorders. 50. 102809–102809. 3 indexed citations
4.
Schwartz, Ilan S., Mari E. Boesen, Graziela Cerchiaro, et al.. (2021). Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial. CMAJ Open. 9(2). E693–E702. 25 indexed citations
5.
Koch, Marcus, et al.. (2021). Hydroxychloroquine for Primary Progressive Multiple Sclerosis. Annals of Neurology. 90(6). 940–948. 29 indexed citations
6.
Koch, Marcus, et al.. (2021). Repurposing Domperidone in Secondary Progressive Multiple Sclerosis. Neurology. 96(18). e2313–e2322. 16 indexed citations
7.
Metz, Luanne M., et al.. (2020). Quetiapine is Not Tolerable to People with MS in Doses Potentially Required to Enhance Myelin Repair (2868). Neurology. 94(15_supplement). 4 indexed citations
8.
Metz, Luanne M., David K.B. Li, Anthony Traboulsee, et al.. (2017). Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis. New England Journal of Medicine. 376(22). 2122–2133. 140 indexed citations
9.
Alba‐Loureiro, Tatiana Carolina, Carolina Demarchi Munhoz, Joilson O. Martins, et al.. (2007). Neutrophil function and metabolism in individuals with diabetes mellitus. Brazilian Journal of Medical and Biological Research. 40(8). 1037–1044. 257 indexed citations
10.
La, Mylinh, Thong Cao, Graziela Cerchiaro, et al.. (2003). A Novel Biological Activity for Galectin-1. American Journal Of Pathology. 163(4). 1505–1515. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026